You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Checkpoint Inhibitor (ICI) therapy

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Frequency of Symptomatic Herpes Virus I and II in HIV Infected

Recruiting
  • HIV Disease
  • +2 more
  • Blood draw
  • Los Angeles, California
    Global Research Institute
Apr 9, 2023

NSCLC, EGFR Positive NSCLC, Oligoprogression Trial in München (Osimertinib, Radiotherapy)

Recruiting
  • NSCLC
  • +2 more
  • München, Germany
    LMU Klinikum der Universität München
May 17, 2022

Non Small Cell Lung Cancer Trial in Shanghai (Trametinib, Anlotinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Jan 16, 2022

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma Trial in Guam,

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +7 more
  • Anchorage, Alaska
  • +1084 more
Aug 24, 2022

Fluid Loss, Enhanced Recovery Trial in New Delhi (Goal directed Fluid Therapy, Conventional Fluid Therapy)

Recruiting
  • Fluid Loss
  • Enhanced Recovery
  • Goal directed Fluid Therapy
  • Conventional Fluid Therapy
  • New Delhi, Please Select, India
    Anita Kulkarni
Sep 6, 2023

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

After Adoptive Transfer of Genetically Modified Cell Products

Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 6, 2023

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

    Recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
      • Milan, Italy
        Ospedale San Raffaele
      Aug 29, 2023

      Glioblastoma Multiforme Trial (WP1066)

      Not yet recruiting
      • Glioblastoma Multiforme
      • (no location specified)
      May 18, 2023

      HIV/AIDS, Trauma Trial in Boston, Toronto (CBT-TSC, Life Steps and Sexual Decision-Making)

      Completed
      • HIV/AIDS
      • Trauma
      • CBT-TSC
      • Life Steps and Sexual Decision-Making
      • Boston, Massachusetts
      • +1 more
      Apr 7, 2023

      Chronic Pain, Knee Pain Chronic, Back Pain, Low Trial in San Francisco (HFIT, TENS, Control)

      Not yet recruiting
      • Chronic Pain
      • +2 more
      • HFIT
      • +2 more
      • San Francisco, California
        Hinge Health, Inc
      Apr 18, 2023

      Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

      Recruiting
      • Thymic Carcinoma
      • Envolizumab combined with radiotherapy
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Sep 3, 2023

      Photo-damaging Trial (Skinceuticals skin care product(CE), fraxel laser therapy, 0.9% normal saline)

      Not yet recruiting
      • Photo-damaging
      • Skinceuticals skin care product(CE)
      • +2 more
      • (no location specified)
      Aug 30, 2023

      Hepatitis B Vaccine Trial (60 µg dose hepatitis B vaccine, 20 µg dose hepatitis B vaccine)

      Completed
      Has Results
      • Hepatitis B Vaccine
      • 60 µg dose hepatitis B vaccine
      • 20 µg dose hepatitis B vaccine
      • (no location specified)
      Nov 26, 2021

      Prospective Research for Elderly Early Breast Cancer Patients

      Recruiting
      • Breast Cancer Female
      • Beijing, China
        Peking Union Medical College Hospital
      Dec 26, 2022

      SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),

      Active, not recruiting
      • SARS-CoV2 Infection
      • +3 more
      • BNT162b2
      • +5 more
      • Long Beach, California
      • +34 more
      Jan 10, 2023

      Gynecologic Cancer, Chemo-induced Peripheral Neuropathy Trial in Durham (Cryotherapy, Compression)

      Not yet recruiting
      • Gynecologic Cancer
      • Chemotherapy-induced Peripheral Neuropathy
      • Cryotherapy
      • Compression
      • Durham, North Carolina
        Duke University Medical Center
      Nov 15, 2023

      Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

      Not yet recruiting
      • Metastatic Hormone-Sensitive Prostate Cancer
      • (no location specified)
      Nov 10, 2023

      Ischemic Stroke, Hemorrhagic Stroke, Chronic Stroke Trial in Salaya (transcranial direct current stimulation (Active),

      Not yet recruiting
      • Ischemic Stroke
      • +3 more
      • transcranial direct current stimulation (Active)
      • +3 more
      • Salaya, Nakonpathom, Thailand
        Faculty of Physical Therapy, Mahidol University
      Nov 12, 2023

      Schizophreniform Disorders Trial in Carrboro, Raleigh (I-CAT, Treatment as Usual)

      Completed
      Has Results
      • Schizophreniform Disorders
      • I-CAT
      • Treatment as Usual
      • Carrboro, North Carolina
      • +3 more
      Feb 9, 2021

      Iron Deficiency (Without Anemia) Trial (Iron, Placebo)

      Not yet recruiting
      • Iron Deficiency (Without Anemia)
      • Iron
      • Placebo
      • (no location specified)
      May 11, 2023

      Convulsion, Non-Epileptic Trial in Birmingham (ReACT, Supportive Therapy)

      Not yet recruiting
      • Convulsion, Non-Epileptic
      • ReACT
      • Supportive Therapy
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 22, 2023

      Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in

      Withdrawn
      • Anatomic Stage IV Breast Cancer AJCC v8
      • +4 more
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Jun 3, 2021

      Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)

      Not yet recruiting
      • Venous Thromboembolism
      • Urologic Cancer
      • Rivaroxaban 10 MG
      • Placebo control
      • (no location specified)
      Jun 16, 2023